Embryonic Stem Cell Trial to Treat Blindness Begins in California
The Jules Stein Eye Institute at the University of California, Los Angeles (UCLA) just announced they will begin a dual-trial stem cell program targeting retinal diseases, including dry AMD.

This research study marks only the second embryonic stem cell program ever conducted in the United States.

http://ping.fm/qGRR5